News

Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial

The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.

Boston Scientific said it initiated the AGENT DCB STANCE trial to assess the safety and effectiveness of the Agent Drug-Coated Balloon (DCB) compared to the standard of care using either percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and/or balloon angioplasty. The trial will enroll more than 1,600 patients and is expected to a primary completion date in 2028.

New physician Medicare payments for the Agent drug-coated balloon set for 2027

Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

Apple has officially introduced the Apple Watch Ultra 3, which will provide notifications when it detects signs of chronic high blood pressure once the technology is cleared by the U.S. Food and Drug Administration (FDA).

U.S. International Federal Trade Commission reviews ban on new Apple Watch pulse oximeter

Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.

Society of Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explains the SCAI initiative to improve outcomes in cardiogenic shock by monitoring and lowering patient lactate levels.

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.

Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO

The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

The U.S. Food and Drug Adminstration (FDA) granted 510(k) clearance for the latest release of Philips Healthcare's Cardiovascular Workspace imaging and information management system. It enables cloud-hosted availability and software-as-a-Service (SaaS) deployment.

FDA clears new cloud-enabled Philips cardiovascular IT system

The cloud-enabled system provides the foundation for future AI-enabled tools, better workflows and analytics.

Drinking coffee may reduce risk of recurrent AFib

Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.

AI-enabled coronary plaque quantification outperforms traditional risk scores

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.

Hispanic PAD patients often face longer hospitalizations, higher costs

Hispanic adults with peripheral artery disease tend to seek care through the emergency department—and they are paying the price.

These aerobic exercises can help lower your blood pressure

Patients hoping to reduce their blood pressure through aerobic exercise certainly have many options to choose from.

Early epinephrine treatment during cardiac arrest increases chance of a good recovery

Patients who received epinephrine within four minutes after the first shock from an AED had a better chance of recovery.

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021.

Around the web

Radiology Business

4D MRI techniques could help advance the development of artificial hearts

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Health Exec

MGMA: Congress needs to act soon to preserve access to telemedicine programs

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

Health Exec

MGMA: Ending ACA subsidies could strain health system, leave millions uninsured

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.